Target intelligence / Profile preview

Toxic heavy metal ion

Molecular classification
Other
01

Overview

Toxic heavy metal ions is not a specific, discrete molecule or receptor but rather a loosely defined group encompassing metal ions such as mercury (Hg²⁺), lead (Pb²⁺), cadmium (Cd²⁺), arsenic (primarily As³⁺/As⁵⁺), thallium (Tl⁺/Tl³⁺), and chromium (mainly Cr⁶⁺) that are highly toxic to various biological systems, including humans, at low concentrations[2][5][7]. These ions often lack essential biological function and exert toxicity through diverse mechanisms: generating reactive oxygen species, inactivating enzymes, and displacing vital metal ions in biomolecules, which can damage nucleic acids, proteins, and cellular membranes[2][3][5][7]. Toxic manifestations vary by metal and can include neurological, renal, developmental, immunological, and carcinogenic effects. Because "toxic heavy metal ions" is not a singular, pharmacologically tractable entity or standard molecular target (like a receptor or enzyme), but rather a collective hazard category, it is not considered a true therapeutic target. Instead, clinical interventions aim to chelate and remove these ions from exposed individuals, primarily using chelating agents[2][5][7]. This category designation is therefore too broad and non-specific for structured drug target annotation.

Other names
Heavy metal ionToxic heavy metalHeavy metal(loid)Heavy metal cation
02

Mechanism of action

Chelation and removal of metal ions from the body

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Systemic toxicityNephrotoxicity (kidney)NeurotoxicityCarcinogenicityBioaccumulationDifficulty achieving selective detoxification without disturbing essential metal ions
06

Interacting drugs

Chelating agents (e.g., dimercaprol, EDTA, DMSA, DMPS)
07

Biomarkers

Blood levels of specific metals (e.g., blood lead, blood mercury)Urinary beta-2 microglobulin (for cadmium)

Beyond the preview

Go deeper on Toxic heavy metal ion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toxic heavy metal ion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call